![Chun Chun Tang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Chun Chun Tang is currently a Director at StemCyte, Inc. since 2014.
Prior to this, Mr. Tang was the Chairman, General Manager & Spokesman at Fountain Biopharma, Inc.
Postes actifs de Chun Chun Tang
Sociétés | Poste | Début |
---|---|---|
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Directeur/Membre du Conseil | 17/04/2014 |
Anciens postes connus de Chun Chun Tang
Sociétés | Poste | Fin |
---|---|---|
FOUNTAIN BIOPHARMA INC | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
StemCyte, Inc.
![]() StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Health Technology |
Fountain Biopharma, Inc.
![]() Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |